Recent insider trading activity from Fawell Stephen, including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 18, 2025 | C4 Therapeutics, Inc. | $CCCC | Fawell Stephen | Director | A | Stock Option (Right to Buy) | 35500 | $0.00 | 35,500.0000 | 70,989,661 | 9999.99% | 0.05% |
| Aug. 29, 2024 | C4 Therapeutics, Inc. | $CCCC | Fawell Stephen | Director | A | Stock Option (Right to Buy) | 65000 | $0.00 | 65,000.0000 | 0 | 9999.99% | 0.00% |